Arvind SmartSpaces Eyes ₹180 Crore Revenue from New Ahmedabad Housing Project

Source: Economictimes
Arth Insight · What this means for your wallet
- Arvind SmartSpaces is launching a new housing project on Kerala-Nalsarovar Road in Ahmedabad.
- The project is expected to bring in ₹180 crore in revenue through a partnership model.
- The development highlights the growing demand for residential properties in Ahmedabad's outskirts.
Real estate developer Arvind SmartSpaces has partnered with a local landowner for a new residential project on Ahmedabad's Kerala-Nalsarovar Road. The development is projected to generate ₹180 crore in revenue as the company expands its footprint in Gujarat.
- ▸Arvind SmartSpaces is launching a new housing project on Kerala-Nalsarovar Road in Ahmedabad.
- ▸The project is expected to bring in ₹180 crore in revenue through a partnership model.
- ▸The development highlights the growing demand for residential properties in Ahmedabad's outskirts.
- ✓Arvind SmartSpaces is launching a new housing project on Kerala-Nalsarovar Road in Ahmedabad.
- ✓The project is expected to bring in ₹180 crore in revenue through a partnership model.
- ✓The development highlights the growing demand for residential properties in Ahmedabad's outskirts.
Strategic Expansion in Ahmedabad
Arvind SmartSpaces Ltd, the real estate arm of the Lalbhai Group, has announced a new residential project in Ahmedabad, signaling robust growth in Gujarat's property market. The company has entered into a strategic partnership with a local landowner to develop a housing project on the Kerala-Nalsarovar Road corridor.
This move is part of the company's broader strategy to capitalize on the increasing demand for residential spaces in emerging suburban areas. By collaborating with a landowner, Arvind SmartSpaces follows an asset-light model, which typically helps developers reduce initial capital expenditure while focusing on construction and sales execution.
Financial Outlook and Market Reach
The developer anticipates that this new venture will unlock a revenue potential of approximately ₹180 crore. This project adds significant value to the company’s existing portfolio, which already features a mix of luxury villas, integrated townships, and mid-range residential apartments across major Indian cities.
The choice of Kerala-Nalsarovar Road is notable as the area is gaining traction for its connectivity and peaceful environment, making it a target for both investors and end-users looking for homes away from the city's central congestion.
Key Highlights of the Development
- Location: Situated on the Kerala-Nalsarovar Road, a growing residential hub in Ahmedabad.
- Revenue Goal: The project is estimated to generate ₹180 crore in sales.
- Model: A joint development partnership with a local landowner.
- Growth Strategy: Enhances Arvind SmartSpaces' presence in its home market of Gujarat.
As the real estate sector in Ahmedabad continues to show resilience, this project is expected to contribute to the city's urban sprawl, offering new options for home buyers in the burgeoning residential corridors.
Investment in real estate involves risks; revenue projections are estimates and not a guarantee of future performance. Consult a financial advisor before investing.
Loan interest rates, processing fees and eligibility are set by the lender and subject to credit approval — verify current terms before applying. Some listings may be sponsored. Not financial advice.
Frequently Asked Questions
Where exactly is the new project located?
The project is situated on the Kerala-Nalsarovar Road, an emerging residential corridor in Ahmedabad.
Who is developing this project?
It is being developed by Arvind SmartSpaces Ltd in partnership with a local landowner.
What is the expected financial scale of this project?
The company expects to generate approximately ₹180 crore in revenue from this specific development.
Join the Arth Vani channels
Daily news summaries, IPO & market alerts on Telegram and WhatsApp.
Because you read about real-estate

ChrysCapital and Tata Capital Inject ₹584 Crore into Linux Laboratories
Linux Laboratories has secured approximately ₹584 crore ($70 million) in equity funding from investment giants ChrysCapital and Tata Capital Healthcare Fund III. This significant investment will enable Linux Laboratories to expand its presence in existing and new therapeutic areas within the healthcare sector.
BreakingSupreme Court Flags High Cancer Drug Prices, Urges Government Price Cap
The Supreme Court has expressed serious concern over the exorbitant pricing of essential medicines, particularly cancer drugs, sold with huge markups. Justices Vikram Nath and SVN Bhatti urged the government to consider a uniform pricing rule to cap Maximum Retail Prices (MRPs), highlighting the burden on ordinary people and taxpayers.
BreakingNiti Aayog Plans National Quality Grades for Hospitals to Boost Patient Choice
Niti Aayog is developing a national quality framework to grade both public and private hospitals in India. This initiative aims to help patients compare healthcare providers more easily and improve overall quality standards. The framework will assess factors like patient safety, clinical outcomes, and readmission rates.
Related Stories

ChrysCapital and Tata Capital Inject ₹584 Crore into Linux Laboratories
Linux Laboratories has secured approximately ₹584 crore ($70 million) in equity funding from investment giants ChrysCapital and Tata Capital Healthcare Fund III. This significant investment will enable Linux Laboratories to expand its presence in existing and new therapeutic areas within the healthcare sector.
BreakingSupreme Court Flags High Cancer Drug Prices, Urges Government Price Cap
The Supreme Court has expressed serious concern over the exorbitant pricing of essential medicines, particularly cancer drugs, sold with huge markups. Justices Vikram Nath and SVN Bhatti urged the government to consider a uniform pricing rule to cap Maximum Retail Prices (MRPs), highlighting the burden on ordinary people and taxpayers.
BreakingNiti Aayog Plans National Quality Grades for Hospitals to Boost Patient Choice
Niti Aayog is developing a national quality framework to grade both public and private hospitals in India. This initiative aims to help patients compare healthcare providers more easily and improve overall quality standards. The framework will assess factors like patient safety, clinical outcomes, and readmission rates.

CDSCO, Home Ministry Boost Efforts to Stop Illegal Pharma Drug Diversion
India's Central Drugs Standard Control Organisation (CDSCO) is stepping up measures to prevent the illegal diversion of pharmaceutical drugs, particularly those containing narcotic substances. This significant move follows a directive from the National Committee for Coordination on Drug Trafficking, with Union Home Minister Amit Shah emphasizing a united strategy to combat evolving drug trafficking challenges. The Drugs Consultative Committee will review existing regulations to recommend critical improvements.